FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2909862497> ?p ?o ?g. }

• W2909862497 abstract "Asthma is the most common chronic disease in children. As suggested by international guidelines, the main goals of asthma treatment are symptoms control and lung function preservation, through a stepwise and control-based approach. The first line therapy based on inhaled corticosteroids may fail to reach control in more than one third of patients, especially adolescents, and in these lung function and quality of life may progressively worsen. Treatment with omalizumab, the first anti-immunoglobulin E recombinant humanized monoclonal antibody, has been definitely approved in pediatric uncontrolled asthma. In this review, we discuss the mechanisms and potential roles of emerging therapies for pediatric severe asthma. Novel biologic drugs (i.e., dupilumab, mepolizumab, reslizumab, and benralizumab) seem to be promising in reducing annual exacerbation rates and steroid-use in glucocorticoid-dependent cases, but available data are few and limited to adolescents and adults. Evidences on the use of the muscarinic antagonist tiotropium as controller medication in pediatric settings are progressively growing, sustaining an application as asthma maintenance treatment in children aged >6 years and in preschool children with persistent asthmatic symptoms, but well powered trials are needed to confirm its safety and efficacy. New inhaled corticosteroids (i.e., ciclesonide and mometasone) are effective as once-daily controller therapy, but long-term studies in the different pediatric ages are needed to compare effectiveness and safety to usual treatments. At present, the role of macrolides in pediatric severe asthma is controversial and their administration is not recommended routinely, but may be considered in children with neutrophilic asthma for reducing daily oral steroids administration and improving lung function. Despite the availability of several novel therapeutic strategies for uncontrolled asthma, future trials targeted at specific pediatric age subgroups are needed to support evidences of safety and efficacy also in children." @default.
• W2909862497 created "2019-01-25" @default.
• W2909862497 creator A5012569202 @default.
• W2909862497 creator A5013898274 @default.
• W2909862497 creator A5042365040 @default.
• W2909862497 date "2019-01-16" @default.
• W2909862497 modified "2023-10-16" @default.
• W2909862497 title "New Drugs for Pediatric Asthma" @default.
• W2909862497 cites W1228606256 @default.
• W2909862497 cites W133487695 @default.
• W2909862497 cites W1501757022 @default.
• W2909862497 cites W1534894365 @default.
• W2909862497 cites W1556943798 @default.
• W2909862497 cites W181439818 @default.
• W2909862497 cites W1876031798 @default.
• W2909862497 cites W1930827660 @default.
• W2909862497 cites W1977296576 @default.
• W2909862497 cites W1983832849 @default.
• W2909862497 cites W1987412090 @default.
• W2909862497 cites W2004147651 @default.
• W2909862497 cites W2008645991 @default.
• W2909862497 cites W2008931469 @default.
• W2909862497 cites W2022429437 @default.
• W2909862497 cites W2029587541 @default.
• W2909862497 cites W2037466531 @default.
• W2909862497 cites W2039467264 @default.
• W2909862497 cites W2049160101 @default.
• W2909862497 cites W2072619523 @default.
• W2909862497 cites W2074621245 @default.
• W2909862497 cites W2075699130 @default.
• W2909862497 cites W2098276532 @default.
• W2909862497 cites W2098968578 @default.
• W2909862497 cites W2115380539 @default.
• W2909862497 cites W2116393998 @default.
• W2909862497 cites W2116395845 @default.
• W2909862497 cites W2119147796 @default.
• W2909862497 cites W2136960553 @default.
• W2909862497 cites W2138355864 @default.
• W2909862497 cites W2139362442 @default.
• W2909862497 cites W2141475970 @default.
• W2909862497 cites W2146096034 @default.
• W2909862497 cites W2146852572 @default.
• W2909862497 cites W2146887625 @default.
• W2909862497 cites W2146955956 @default.
• W2909862497 cites W2146960414 @default.
• W2909862497 cites W2150634254 @default.
• W2909862497 cites W2160953471 @default.
• W2909862497 cites W2164548578 @default.
• W2909862497 cites W2166363941 @default.
• W2909862497 cites W2168849280 @default.
• W2909862497 cites W2170341353 @default.
• W2909862497 cites W2176892781 @default.
• W2909862497 cites W2267379549 @default.
• W2909862497 cites W2289833205 @default.
• W2909862497 cites W2338443462 @default.
• W2909862497 cites W2344672413 @default.
• W2909862497 cites W2357940608 @default.
• W2909862497 cites W2511120040 @default.
• W2909862497 cites W2513258422 @default.
• W2909862497 cites W2535013036 @default.
• W2909862497 cites W2537532278 @default.
• W2909862497 cites W2546744840 @default.
• W2909862497 cites W2582374071 @default.
• W2909862497 cites W2585010481 @default.
• W2909862497 cites W2587152716 @default.
• W2909862497 cites W262668985 @default.
• W2909862497 cites W2767294221 @default.
• W2909862497 cites W2774063065 @default.
• W2909862497 cites W2782732750 @default.
• W2909862497 cites W2791163322 @default.
• W2909862497 cites W2799456210 @default.
• W2909862497 cites W2803941918 @default.
• W2909862497 cites W2804101208 @default.
• W2909862497 cites W2805002966 @default.
• W2909862497 cites W2806853209 @default.
• W2909862497 cites W2956481022 @default.
• W2909862497 cites W4237805405 @default.
• W2909862497 cites W4242285512 @default.
• W2909862497 doi "https://doi.org/10.3389/fped.2018.00432" @default.
• W2909862497 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6343461" @default.
• W2909862497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30701170" @default.
• W2909862497 hasPublicationYear "2019" @default.
• W2909862497 type Work @default.
• W2909862497 sameAs 2909862497 @default.
• W2909862497 citedByCount "9" @default.
• W2909862497 countsByYear W29098624972019 @default.
• W2909862497 countsByYear W29098624972020 @default.
• W2909862497 countsByYear W29098624972021 @default.
• W2909862497 countsByYear W29098624972022 @default.
• W2909862497 countsByYear W29098624972023 @default.
• W2909862497 crossrefType "journal-article" @default.
• W2909862497 hasAuthorship W2909862497A5012569202 @default.
• W2909862497 hasAuthorship W2909862497A5013898274 @default.
• W2909862497 hasAuthorship W2909862497A5042365040 @default.
• W2909862497 hasBestOaLocation W29098624971 @default.
• W2909862497 hasConcept C141105273 @default.
• W2909862497 hasConcept C159654299 @default.
• W2909862497 hasConcept C177713679 @default.
• W2909862497 hasConcept C187212893 @default.
• W2909862497 hasConcept C203014093 @default.

• next